<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We evaluated the inhibitory activity of a novel prostacyclin analog, OP-2507 (15-cis-(4-n-propylcyclohexyl)-16,17,18,19,20-pentanor-9-deo xy-6,9 alpha- nitriloprostaglandin F1 <z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi>) on the <z:hpo ids='HP_0002181'>brain edema</z:hpo> induced by occlusion of the middle cerebral artery in cats </plain></SENT>
<SENT sid="1" pm="."><plain>Middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 4h caused a decrease of regional cerebral blood flow </plain></SENT>
<SENT sid="2" pm="."><plain>The specific gravity of the cerebral cortex measured 4h after the middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> as an index of <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> showed a significant reduction </plain></SENT>
<SENT sid="3" pm="."><plain>Intravenous infusion of OP-2507 at infusion rates of 10 and 50 ng/kg per min was started 30 min before the middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and was continued for 4.5 h </plain></SENT>
<SENT sid="4" pm="."><plain>While OP-2507 did not affect the blood pressure, heart rate and regional cerebral blood flow before and after the middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, the reduction of the specific gravity of cerebral cortex was significantly prevented by OP-2507 treatment at both doses </plain></SENT>
<SENT sid="5" pm="."><plain>Prostacyclin prevented the reduction of the specific gravity only at the higher dose of 50 ng/kg per min </plain></SENT>
<SENT sid="6" pm="."><plain>The present results indicate the potential usefulness of OP-2507 in <z:hpo ids='HP_0011009'>acute</z:hpo> ischemic <z:e sem="disease" ids="C0234387" disease_type="Disease or Syndrome" abbrv="">cerebral disorders</z:e> </plain></SENT>
</text></document>